2025 annual financial data

Propanc Biopharma 2025 Financial results

Propanc Biopharma 2025 financial results with verified reported values.

Direct answer

Revenue was 0 USD.

Operating income was -57,278,131 USD and net income was -58,923,300 USD.
Operating cash flow was -405,168 USD.

Get free Propanc Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-57,278,131 USD
Net income
-58,923,300 USD
Operating cash flow
-405,168 USD